VT
EW icon

Vise Technologies’s Edwards Lifesciences EW Stock Holding History

Vise Technologies’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,113
Closed -$606K – 1884
2026
Q1 		$606K Hold
7,113
– – 0.01% 780
2025
Q4 		$606K Buy
7,113
+417
+6% +$34.2K 0.01% 785
2025
Q3 		$521K Sell
6,696
-10,759
-62% -$841K 0.02% 654
2025
Q2 		$1.37M Buy
+17,455
New +$1.3M 0.06% 355
2024
Q4 		$386K Buy
5,209
+1,702
+49% +$119K 0.03% 508
2024
Q3 		$231K Sell
3,507
-3,138
-47% -$228K 0.03% 532
2024
Q2 		$614K Buy
6,645
+2,104
+46% +$186K 0.11% 194
2024
Q1 		$434K Buy
+4,541
New +$381K 0.09% 225

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Vise Technologies's EW Position: Q2 2026 in Review

Vise Technologies sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 7,113 shares — an estimated $606K sold.

Vise Technologies first reported a position in EW in Q1 2024 and held it in 8 quarters. The position peaked at $1.37M in Q2 2025. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Vise Technologies reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Vise Technologies sold 7,113 Edwards Lifesciences shares in Q2 2026, an estimated $606K.
  • Vise Technologies first reported a position in Edwards Lifesciences in Q1 2024 and held it in 8 quarters.
  • Vise Technologies's Edwards Lifesciences position peaked at $1.37M in Q2 2025.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Vise Technologies's 13F filing for Q2 2026, filed 11 Aug 2026.